| Heading: |
Pancreatic Enzyme Replacement Therapy: Imports |
| Question ID: |
1792330 |
| UIN: |
44156 |
| House: |
Commons |
| Date tabled: |
2025-04-03 |
| Asking Member ID: |
5157 |
| Asking Member display name: |
Susan Murray
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Susan Murray
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 March 2025 to Question 35462 on Pancreatic Enzyme Replacement Therapy shortages, if he will publish the volume of unlicensed pancreatic enzyme replacement therapy stock |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-09 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department does not hold details on the volume of unlicensed pancreatic enzyme replacement therapy (PERT) stock imported since 1 January 2024. The Department continues to work with specialist importers who have sourced unlicensed stock to assist in co... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |